Intracerebral metastases of malignant melanoma and their recurrences—A clinical analysis
Authors:
- Dorothea MillerDMDorothea Miller
- Valeria ZappalaVZValeria Zappala
- Nicolai El HindyNHNicolai El Hindy
- Elisabeth LivingstoneELElisabeth Livingstone
- Dirk SchadendorfDSDirk Schadendorf
- Ulrich SureUSUlrich Sure
- Ibrahim Erol SandalciogluISIbrahim Erol Sandalcioglu
- 1 September 2013
- journal article
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 115 (9) , 1721-1728
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Number of metastases, serum lactate dehydrogenase level, and type of treatment are prognostic factors in patients with brain metastases of malignant melanomaCancer, 2010
- Prognostic factors for survival in melanoma patients with brain metastasesCancer, 2010
- Factors influencing the risk of local recurrence after resection of a single brain metastasisJournal of Neurosurgery, 2010
- Incidence Proportions of Brain Metastases in Patients Diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance SystemJournal of Clinical Oncology, 2004
- Determinants of Outcome in Melanoma Patients With Cerebral MetastasesJournal of Clinical Oncology, 2004
- Selection of Patients With Melanoma Brain Metastases for Aggressive TreatmentAmerican Journal of Clinical Oncology, 2003
- Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanomaJournal of Neurosurgery, 1998
- Central Nervous System Metastases in Malignant MelanomaNeurosurgery, 1981
- Malignant melanoma and central nervous system metastases.Incidence, diagnosis, treatment and survivalCancer, 1978
- The current causes of death in patients with malignant melanoma1978